Abstracto

Type 2 diabetes, medical knowledge and pharmaceutical innovations.

Da-Yong Lu, Jin-Yu Che, Nagendra Sastry Yarla, Hong-Ying Wu, , Bin Xu, Shu-Yun Wu, Yi Lu, Ting-Ren Lu , , , Hong Zhu

Type 2 Diabetes Mellitus (T2DM) is an emerging medical crisis over the past two decades. However, the causality, pathogenesis and therapeutics of type 2 diabetes are currently too refractory to be easily managed in the clinics. Medical knowledge and therapeutic options for T2DM treatments are still of great medical significance. We welcome therapeutics of both cutting-edge and traditional for anti-diabetic treatments in future